Allogeneic HCT

PROCEDURE3 trials

Sponsors

Eastern Cooperative Oncology Group, Monica Thakar, Wake Forest University Health Sciences

Conditions

Acute Myeloid Leukemia (AML)CNS TumorsEwing SarcomaLeukemiaNeuroblastomaOsteosarcomaRhabdomyosarcoma

Phase 2

Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors

TerminatedNCT02100891

Monica ThakarCNS Tumors, Ewing Sarcoma, Neuroblastoma +2

Start: 2013-03-20End: 2020-07-15Updated: 2025-03-19

Phase 3

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

CompletedNCT00049517

Eastern Cooperative Oncology GroupLeukemia

Start: 2002-12-19End: 2019-12-31Updated: 2023-06-15

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

TerminatedNCT02927938

Wake Forest University Health SciencesAcute Myeloid Leukemia (AML)

Start: 2016-09-30End: 2018-10-05Updated: 2022-04-21

Related Papers

Characteristics and prognostic impact of<i>IDH</i>mutations in AML: a COG, SWOG, and ECOG analysis

Blood Advances2023-06-0250 citations

Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis

Cancer2023-04-258 citations

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

Leukemia Research2022-10-217 citations

Phase II trial using haploidentical hematopoietic cell transplantation (HCT) followed by donor natural killer (NK) cell infusion and sirolimus maintenance for patients with high-risk solid tumors.

Journal of Clinical Oncology2020-05-2013 citations

Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614)

Blood2018-11-29

ANTHRACYCLINE DOSE INTENSIFICATION IN DIFFUSE LARGE <scp>B</scp>‐CELL LYMPHOMA

Hematological Oncology2017-06-01

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia.

2016-06-0115 citations

Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups

Blood2016-01-11127 citations

Effect of Genetic Profiling on Prediction of Therapeutic Resistance and Survival in Adult Acute Myeloid Leukemia

Blood2014-12-06

Anthracycline dose intensification in acute myeloid leukemia.

2009-09-01687 citations